US Patent Issued to Eli Lilly and Co. on Feb. 24 for "Dual amylin and calcitonin receptor agonists and uses thereof" (Indiana Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,430, issued on Feb. 24, was assigned to Eli Lilly and Co. (Indianapolis).

"Dual amylin and calcitonin receptor agonists and uses thereof" was invented by Tamer Coskun (Carmel, Ind.) and Hongchang Qu (Carmel, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure related to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity, and/or dyslipidemia. The disclosure relates to compounds that agonize both the calcitonin and amylin receptors and can lower food intake, body weight, glucose and/or triglycerides, so can be used to treat diabetes, obesity and/or dyslipidemia. The present...